Novartis India Ltd Share Price

672.25
(-2.48%)
Oct 25, 2023|03:57:48 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open691.05
  • Day's High698.2
  • 52 Wk High796.5
  • Prev. Close689.35
  • Day's Low668.35
  • 52 Wk Low668.35
  • Turnover (lac)79.57
  • P/E33.14
  • Face Value5
  • Book Value301.66
  • EPS33.7
  • Mkt. Cap (Cr.)1,659.84
  • Div. Yield2.24
No Records Found

Novartis India Ltd KEY RATIOS

Sector

Trading

Open

691.05

Prev. Close

689.35

Turnover(Lac.)

79.57

Day's High

698.2

Day's Low

668.35

52 Week's High

796.5

52 Week's Low

668.35

Book Value

301.66

Face Value

5

Mkt Cap (₹ Cr.)

1,659.84

P/E

33.14

EPS

33.7

Divi. Yield

2.24

Novartis India Ltd Corporate Action

10 May 2024

12:00 AM

BookCloser

arrow

10 May 2024

12:00 AM

Dividend

Dividend Amount: 25

arrow

28 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

10 May 2023

12:00 AM

AGM

Announcement Date: 10 May, 2023

arrow

Novartis India Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Novartis India Ltd SHAREHOLDING SNAPSHOT

24 Jul, 2024|04:45 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.67%

Foreign: 70.67%

Indian: 0.00%

Non-Promoter- 0.72%

Institutions: 0.72%

Non-Institutions: 28.60%

Custodian: 0.00%

Share Price

Novartis India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

12.34

12.34

12.34

12.34

Preference Capital

0

0

0

0

Reserves

732.48

763.32

679.36

698.85

Net Worth

744.82

775.66

691.7

711.19

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

399.87

381.35

438.25

563.88

yoy growth (%)

4.85

-12.98

-22.27

-14.07

Raw materials

-178.13

-146.62

-182.32

-245.51

As % of sales

44.54

38.44

41.6

43.53

Employee costs

-101.89

-108.51

-113.87

-144.53

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

45.82

40.04

28.64

157.52

Depreciation

-9.65

-12.16

-13.14

-2.53

Tax paid

0.1

-19.14

-18.56

-79.16

Working capital

-78.83

-15.29

-30.38

-167.55

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

4.85

-12.98

-22.27

-14.07

Op profit growth

1.19

122.69

-292.48

-124.96

EBIT growth

6.13

36.22

-78.51

76.36

Net profit growth

-117.79

107.34

-87.13

36.94

View Ratios

No Record found

Novartis India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

2,995.35

121.883,40,421.43776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

834.2

7229,215.49125.880.39721.5167.87

Cello World Ltd

CELLO

948.55

340.0420,955.3618.620.15260.7765.65

Redington Ltd

REDINGTON

202.36

15.215,815.3160.573.0610,490.2446.35

Honasa Consumer Ltd

HONASA

467.2

125.0315,121.1326.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Novartis India Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

C Snook

Independent Director

Sandra Martryes

Independent Director

SANKER PARAMESWARAN

Whole Time Director & CFO

Shilpa Joshi

Company Sec. & Compli. Officer

Chandni Maru

Independent Director

Gira Sardesai

Whole Time Director

Falin Majmudar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the worlds second largest pharmaceutical company was incorporated on 13 December 1947. The Company is focused on manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates in four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz. The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886. In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years. In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd. joined to form Novartis. In the year 1998, the company had set-up the Novartis Institute for Functional Genomics. During the year 2000, Novartis acquired the products Famvir and Vectavir/Denavir from SmithKline Beecham also in the same year, the company started to provide treatment to leprosy patients worldwide through World Health Organisation (WHO). Also in 2000, NIL had started JEET (Joint Effort to Eradicate Tuberculosis) with the aim of increasing awareness among TB patents and to involve doctors more actively in the fight against disease. After a year, Novartis Respiratory Research Centre, the largest of its kind in
Read More

Company FAQs

What is the Novartis India Ltd share price today?

Down Arrow

The Novartis India Ltd shares price on N/A is Rs.₹1115 today.

What is the Market Cap of Novartis India Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Novartis India Ltd is ₹2753.02 Cr. as of 24 Jul ‘24

What is the PE and PB ratio of Novartis India Ltd?

Down Arrow

The PE and PB ratios of Novartis India Ltd is 33.14 and 3.70 as of 24 Jul ‘24

What is the 52 Week High and Low of Novartis India Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Novartis India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Novartis India Ltd is ₹599.95 and ₹1224 as of 24 Jul ‘24

What is the CAGR of Novartis India Ltd?

Down Arrow

Novartis India Ltd's CAGR for 5 Years at 11.66%, 3 Years at 4.46%, 1 Year at 43.08%, 6 Month at 26.55%, 3 Month at 9.02% and 1 Month at 1.87%.

What is the shareholding pattern of Novartis India Ltd?

Down Arrow

The shareholding pattern of Novartis India Ltd is as follows:
Promoters - 70.68 %
Institutions - 0.72 %
Public - 28.60 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.